Discover new QPS pharmacology models coming soon, learn how the QPS MASH model can work for you, and stay informed with the latest scientific insights on the QPS Blog.
Liver Fibrosis (GAN models with extended induction)
Corneal epithelial wound healing model
Chronic Kidney Disease (CKD) model
Please reach out today to share your interest in any of our currently available pharmacology models, or any of the models we will have available "coming soon".
Request a meeting with the QPS bioanalysis, preclinical and clinical research experts to learn more about our capabilities as a full-service, global CRO.
Synthetic and semi-synthetic opioids offer powerful pain relief. Unfortunately, these drugs are also associated with negative outcomes, including addiction and overdose. The U.S. Centers for Disease Control and Prevention reported 48,422 deaths related to synthetic opioids in...
Glucagon-like peptide (GLP-1) receptor agonists (GLP-1 RAs) are transformative medications for millions of people managing diabetes and obesity. Amid research demonstrating the many benefits gained from these drugs...
We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
QPS Holdings, LLC | Three Innovation Way Suite 240 | Newark , DE 19711 US
